PlainRecalls
FDA Drug Moderate Class II Terminated

Cefuroxime 10 mg/mL in Sodium Chloride, Intravitreal injection, 1 mL in a 2mL Vial, Ophthalmic Use Only, Office Use Only, Leiter's (800) 292-6772- 17 Great Oaks Blvd., San Jose, CA 95119. NDC: 70360-007-35.

Reported: March 13, 2019 Initiated: February 19, 2019 #D-0518-2019

Product Description

Cefuroxime 10 mg/mL in Sodium Chloride, Intravitreal injection, 1 mL in a 2mL Vial, Ophthalmic Use Only, Office Use Only, Leiter's (800) 292-6772- 17 Great Oaks Blvd., San Jose, CA 95119. NDC: 70360-007-35.

Reason for Recall

Incorrect Product Formulation; compounded sterile drug reconstituted using sterile water instead of sterile 0.9% Sodium Chloride.

Details

Units Affected
569 vials
Distribution
CA, AZ, MI, NY
Location
San Jose, CA

Frequently Asked Questions

What product was recalled?
Cefuroxime 10 mg/mL in Sodium Chloride, Intravitreal injection, 1 mL in a 2mL Vial, Ophthalmic Use Only, Office Use Only, Leiter's (800) 292-6772- 17 Great Oaks Blvd., San Jose, CA 95119. NDC: 70360-007-35.. Recalled by Leiter's Enterprises, Inc.. Units affected: 569 vials.
Why was this product recalled?
Incorrect Product Formulation; compounded sterile drug reconstituted using sterile water instead of sterile 0.9% Sodium Chloride.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 13, 2019. Severity: Moderate. Recall number: D-0518-2019.